{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:31:29Z","timestamp":1793043089869,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhandsurg.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Hand Surgery"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.jhsa.2023.10.013","type":"journal-article","created":{"date-parts":[[2023,12,2]],"date-time":"2023-12-02T17:11:41Z","timestamp":1701537101000},"page":"260-266","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Amyloidosis and Considerations for the Hand Surgeon"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-2376-204X","authenticated-orcid":false,"given":"Chelsea R.","family":"Brown","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Bergin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Nicole","family":"Deal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jhsa.2023.10.013_bib1","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1159\/000506696","article-title":"The pathology of amyloidosis in classification: a review","volume":"143","author":"Picken","year":"2020","journal-title":"Acta Haematol"},{"issue":"3","key":"10.1016\/j.jhsa.2023.10.013_bib2","first-page":"472","article-title":"A\u00a0modern primer on light chain amyloidosis in 592 patients with mass spectrometry-verified typing","volume":"94","author":"Muchtar","year":"2019","journal-title":"Mayo Clin Proc"},{"issue":"12 suppl 3","key":"10.1016\/j.jhsa.2023.10.013_bib6","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3949\/ccjm.84.s3.02","article-title":"Cardiac amyloidosis: an update on diagnosis and treatment","volume":"84","author":"Donnelly","year":"2017","journal-title":"Cleve Clin J Med"},{"issue":"10","key":"10.1016\/j.jhsa.2023.10.013_bib3","doi-asserted-by":"crossref","first-page":"e488","DOI":"10.5435\/JAAOS-D-20-01146","article-title":"Orthopaedic manifestations of amyloidosis","volume":"29","author":"Zhang","year":"2021","journal-title":"J\u00a0Am Acad Orthop Surg"},{"issue":"4","key":"10.1016\/j.jhsa.2023.10.013_bib4","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/0002-9343(83)90443-6","article-title":"Frequency and distribution of senile cardiovascular amyloid. A clinicopathologic correlation","volume":"75","author":"Cornwell","year":"1983","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.jhsa.2023.10.013_bib5","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1185\/03007995.2012.754348","article-title":"THAOS\u2013The Transthyretin Amyloidosis Outcomes Survey: initial report on clinical manifestations in patients with hereditary and wild-type transthyretin amyloidosis","volume":"29","author":"Coelho","year":"2013","journal-title":"Curr Med Res Opin"},{"issue":"10","key":"10.1016\/j.jhsa.2023.10.013_bib7","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.jhsa.2019.06.016","article-title":"Carpal tunnel syndrome: a potential early, red-flag sign of amyloidosis","volume":"44","author":"Donnelly","year":"2019","journal-title":"J\u00a0Hand Surg Am"},{"issue":"1","key":"10.1016\/j.jhsa.2023.10.013_bib8","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41572-018-0034-3","article-title":"Systemic immunoglobulin light chain amyloidosis","volume":"4","author":"Merlini","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"25","key":"10.1016\/j.jhsa.2023.10.013_bib9","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1016\/j.jacc.2016.03.593","article-title":"Efficacy of chemotherapy for light-chain amyloidosis in patients presenting with symptomatic heart failure","volume":"67","author":"Sperry","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"145","key":"10.1016\/j.jhsa.2023.10.013_bib10","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0046-2017","article-title":"The lung in amyloidosis","volume":"26","author":"Milani","year":"2017","journal-title":"Eur Respir Rev"},{"issue":"17","key":"10.1016\/j.jhsa.2023.10.013_bib11","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/j.jacc.2018.07.092","article-title":"Tenosynovial and cardiac amyloidosis in patients undergoing carpal tunnel release","volume":"72","author":"Sperry","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jhsa.2023.10.013_bib12","doi-asserted-by":"crossref","unstructured":"Gannon NP, Ward CM. Results of implementation of amyloidosis screening for patients undergoing carpal tunnel release. J Hand Surg Am. Published online January 14, 2023. https:\/\/doi.org\/10.1016\/j.jhsa.2022.09.005","DOI":"10.1016\/j.jhsa.2022.09.005"},{"issue":"6","key":"10.1016\/j.jhsa.2023.10.013_bib13","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jhsa.2022.02.013","article-title":"Prevalence and subtypes of tenosynovial amyloid in patients undergoing carpal tunnel release","volume":"47","author":"DiBenedetto","year":"2022","journal-title":"J\u00a0Hand Surg Am"},{"issue":"6","key":"10.1016\/j.jhsa.2023.10.013_bib14","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s12265-019-09895-0","article-title":"Prevalence of cardiac amyloidosis in patients with carpal tunnel syndrome","volume":"12","author":"Zegri-Reiriz","year":"2019","journal-title":"J\u00a0Cardiovasc Transl Res"},{"issue":"1","key":"10.1016\/j.jhsa.2023.10.013_bib15","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12891-020-03912-z","article-title":"Musculoskeletal pathology as an early warning sign of systemic amyloidosis: a systematic review of amyloid deposition and orthopedic surgery","volume":"22","author":"Wininger","year":"2021","journal-title":"BMC Musculoskelet Disord"},{"issue":"6","key":"10.1016\/j.jhsa.2023.10.013_bib16","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jhsa.2022.01.022","article-title":"Risk of amyloidosis and heart failure among patients undergoing surgery for trigger digit or carpal tunnel syndrome: a nationwide cohort study with implications for screening","volume":"47","author":"Sood","year":"2022","journal-title":"J\u00a0Hand Surg Am"},{"issue":"10","key":"10.1016\/j.jhsa.2023.10.013_bib17","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.jacc.2022.06.026","article-title":"Screening for cardiac amyloidosis 5 to 15 years after surgery for bilateral carpal tunnel syndrome","volume":"80","author":"Westin","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"14","key":"10.1016\/j.jhsa.2023.10.013_bib18","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.2106\/JBJS.20.02093","article-title":"Diagnosing systemic amyloidosis presenting as carpal tunnel syndrome: a risk nomogram to guide biopsy at time of carpal tunnel release","volume":"103","author":"Sood","year":"2021","journal-title":"J\u00a0Bone Joint Surg Am"},{"issue":"3","key":"10.1016\/j.jhsa.2023.10.013_bib19","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1142\/S2424835520500381","article-title":"The tenosynovitis of fingers associated with transthyretin amyloidosis","volume":"25","author":"Hara","year":"2020","journal-title":"J\u00a0Hand Surg Asian Pac Vol"},{"issue":"3","key":"10.1016\/j.jhsa.2023.10.013_bib20","first-page":"120","article-title":"Trigger finger and amyloid cardiomyopathy, usual suspect; amyloid deposition","volume":"9","author":"\u00c7atal","year":"2020","journal-title":"Hand Microsurg"},{"issue":"6","key":"10.1016\/j.jhsa.2023.10.013_bib21","first-page":"2109","article-title":"Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy","volume":"268","author":"Adams","year":"2021","journal-title":"J\u00a0Neurol"},{"issue":"10","key":"10.1016\/j.jhsa.2023.10.013_bib22","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1001\/jama.2017.9236","article-title":"Association between ruptured distal biceps tendon and wild-type transthyretin cardiac amyloidosis","volume":"318","author":"Geller","year":"2017","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.jhsa.2023.10.013_bib23","doi-asserted-by":"crossref","first-page":"996","DOI":"10.3390\/diagnostics11060996","article-title":"Nuclear imaging for the diagnosis of cardiac amyloidosis in 2021","volume":"11","author":"Li","year":"2021","journal-title":"Diagnostics (Basel)"},{"issue":"9","key":"10.1016\/j.jhsa.2023.10.013_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1371","article-title":"Advances in the treatment of hereditary transthyretin amyloidosis: a review","volume":"9","author":"Gertz","year":"2019","journal-title":"Brain Behav"},{"issue":"4","key":"10.1016\/j.jhsa.2023.10.013_bib25","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.jaccao.2021.06.006","article-title":"ATTR Amyloidosis: current and emerging management strategies: JACC: CardioOncology state-of-the-art review","volume":"3","author":"Griffin","year":"2021","journal-title":"JACC Cardiooncol"},{"issue":"3","key":"10.1016\/j.jhsa.2023.10.013_bib26","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.cardfail.2019.01.006","article-title":"Clinical experience with the use of doxycycline and ursodeoxycholic acid for the treatment of transthyretin cardiac amyloidosis","volume":"25","author":"Karlstedt","year":"2019","journal-title":"J\u00a0Card Fail"},{"issue":"2","key":"10.1016\/j.jhsa.2023.10.013_bib27","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s10741-021-10143-4","article-title":"The use of diflunisal for transthyretin cardiac amyloidosis: a review","volume":"27","author":"Ibrahim","year":"2022","journal-title":"Heart Fail Rev"},{"issue":"11","key":"10.1016\/j.jhsa.2023.10.013_bib28","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.jhsa.2023.10.013_bib29","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.008193","article-title":"Long-term survival with tafamidis in patients with transthyretin amyloid cardiomyopathy","volume":"15","author":"Elliott","year":"2022","journal-title":"Circ Heart Fail"},{"issue":"28","key":"10.1016\/j.jhsa.2023.10.013_bib30","doi-asserted-by":"crossref","first-page":"3252","DOI":"10.1200\/JCO.20.01285","article-title":"Bortezomib, melphalan, and dexamethasone for light-chain amyloidosis","volume":"38","author":"Kastritis","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.jhsa.2023.10.013_bib31","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.jhsa.2023.10.013_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13506129.2022.2091985","article-title":"Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a randomized clinical trial","volume":"30","author":"Adams","year":"2023","journal-title":"Amyloid"},{"issue":"1","key":"10.1016\/j.jhsa.2023.10.013_bib33","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1716793","article-title":"Inotersen treatment for patients with hereditary transthyretin amyloidosis","volume":"379","author":"Benson","year":"2018","journal-title":"N\u00a0Engl J Med"}],"container-title":["The Journal of Hand Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0363502323005609?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0363502323005609?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T23:09:50Z","timestamp":1759792190000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0363502323005609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0363502323005609"],"URL":"https:\/\/doi.org\/10.1016\/j.jhsa.2023.10.013","relation":{},"ISSN":["0363-5023"],"issn-type":[{"value":"0363-5023","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amyloidosis and Considerations for the Hand Surgeon","name":"articletitle","label":"Article Title"},{"value":"The Journal of Hand Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhsa.2023.10.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American Society for Surgery of the Hand. All rights reserved.","name":"copyright","label":"Copyright"}]}}